knowledge -WSS

knowledge

author：Wikipedia 2025-08-23 06:45:20 - browse：6

The Food and Drug Administration is poised to tell drug and medical device makers how to better include people of color in the clinical trials that test whether products work and are safe, an agency official said Wednesday. Those guidelines are five months late.

To ensure that drugs work for everyone, they must be tested on a representative sample of people. But researchers have found that many clinical trials exclude the people of color who are often most affected by the diseases that drugs treat.

To help fix that problem, Congress passed a law requiring companies to give the FDA their plans for diversifying clinical trials. As part of that process, the agency was expected to issue guidance by the end of last year.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： FDA's naming rule on biosimilars has undermined competition

hotspot

WSS

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

Decaf coffee targeted by food safety group under obscure FDA rule

Belarusian journalist sentenced to 4 years in prison as crackdown continues

Patient advocates debate FDA's accelerated approval process

GOP inquiry over gain

Supreme Court mifepristone arguments center on docs' right to sue

Wikipedia

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Wikipedia

Apple is now the first public company to be valued at $3 trillion

Illumina to lay off 10% of research and development team

Malaria cases in Florida and Texas: Here’s what you need to know

Eliminate the waiting period for sterilization covered by Medicaid

New air purifier tech could be key to improving indoor air quality

Here's how to stay safe from wildfire smoke amid reduced air quality

Tori Bowie and the unacceptable rates of Black maternal death

Roche subsidiary Foundation Medicine opens new headquarters

Bright Health sells Medicare Advantage business to Molina

Medical experts exlpore how to eliminate bias in clinical algorithms

focus

Eating disorder hotline's move to chatbot carried cost for volunteers

States should stop sabotaging methadone treatment reform

Supreme Court rules employers must be more accommodating of religious observance

Decaf coffee targeted by food safety group under obscure FDA rule

The Readout: Lenmeldy, GLP

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

entertainment

hotspot

Wikipedia

hotspot